Literature DB >> 32346077

Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile.

Lotte E van der Wagen1,2, Alberto Miranda-Bedate2, Anke Janssen2, Febilla Fernando2, Nagesha Appukudige2, Sanne van Dooremalen2, Kasper Westinga3, Rick Admiraal4, Magdalena J Lorenowicz5, Gerwin Huls6, Jeroen J W M Janssen7, Annoek E C Broers8, Walter J F M van der Velden9, Rien van Marwijk Kooy10, Mette D Hazenberg11, Colin de Haar3, Caroline Lindemans12, Jaap Jan Boelens2,13, Jürgen Kuball14,15.   

Abstract

Entities:  

Year:  2020        PMID: 32346077     DOI: 10.1038/s41409-020-0910-9

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

1.  EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.

Authors:  Thao M Nguyen; Agnes Arthur; John D Hayball; Stan Gronthos
Journal:  Stem Cells Dev       Date:  2013-06-29       Impact factor: 3.272

2.  Differential analysis of genome-wide methylation and gene expression in mesenchymal stem cells of patients with fractures and osteoarthritis.

Authors:  Alvaro Del Real; Flor M Pérez-Campo; Agustín F Fernández; Carolina Sañudo; Carmen G Ibarbia; María I Pérez-Núñez; Wim Van Criekinge; Maarten Braspenning; María A Alonso; Mario F Fraga; Jose A Riancho
Journal:  Epigenetics       Date:  2016-12-16       Impact factor: 4.528

3.  Sox11-modified mesenchymal stem cells (MSCs) accelerate bone fracture healing: Sox11 regulates differentiation and migration of MSCs.

Authors:  Liangliang Xu; Shuo Huang; Yonghui Hou; Yang Liu; Ming Ni; Fanbiao Meng; Kuixing Wang; Yunfeng Rui; Xiaohua Jiang; Gang Li
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

4.  Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target.

Authors:  S Horvath; B Zhang; M Carlson; K V Lu; S Zhu; R M Felciano; M F Laurance; W Zhao; S Qi; Z Chen; Y Lee; A C Scheck; L M Liau; H Wu; D H Geschwind; P G Febbo; H I Kornblum; T F Cloughesy; S F Nelson; P S Mischel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

5.  Genetics of gene expression and its effect on disease.

Authors:  Valur Emilsson; Gudmar Thorleifsson; Bin Zhang; Amy S Leonardson; Florian Zink; Jun Zhu; Sonia Carlson; Agnar Helgason; G Bragi Walters; Steinunn Gunnarsdottir; Magali Mouy; Valgerdur Steinthorsdottir; Gudrun H Eiriksdottir; Gyda Bjornsdottir; Inga Reynisdottir; Daniel Gudbjartsson; Anna Helgadottir; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Unnur Styrkarsdottir; Solveig Gretarsdottir; Kristinn P Magnusson; Hreinn Stefansson; Ragnheidur Fossdal; Kristleifur Kristjansson; Hjortur G Gislason; Tryggvi Stefansson; Bjorn G Leifsson; Unnur Thorsteinsdottir; John R Lamb; Jeffrey R Gulcher; Marc L Reitman; Augustine Kong; Eric E Schadt; Kari Stefansson
Journal:  Nature       Date:  2008-03-16       Impact factor: 49.962

6.  Functional organization of the transcriptome in human brain.

Authors:  Michael C Oldham; Genevieve Konopka; Kazuya Iwamoto; Peter Langfelder; Tadafumi Kato; Steve Horvath; Daniel H Geschwind
Journal:  Nat Neurosci       Date:  2008-10-12       Impact factor: 24.884

7.  Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms.

Authors:  Carolina Oliveira Rodini; Patrícia Benites Gonçalves da Silva; Amanda Faria Assoni; Valdemir Melechco Carvalho; Oswaldo Keith Okamoto
Journal:  Oncotarget       Date:  2018-05-15

8.  GEF-H1 controls focal adhesion signaling that regulates mesenchymal stem cell lineage commitment.

Authors:  I-Husan Huang; Cheng-Te Hsiao; Jui-Chung Wu; Rong-Fong Shen; Ching-Yi Liu; Yang-Kao Wang; Yu-Chen Chen; Chi-Ming Huang; Juan C del Álamo; Zee-Fen Chang; Ming-Jer Tang; Kay-Hooi Khoo; Jean-Cheng Kuo
Journal:  J Cell Sci       Date:  2014-08-08       Impact factor: 5.285

9.  Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional decline.

Authors:  Marco L Hennrich; Natalie Romanov; Patrick Horn; Samira Jaeger; Volker Eckstein; Violetta Steeples; Fei Ye; Ximing Ding; Laura Poisa-Beiro; Mang Ching Lai; Benjamin Lang; Jacqueline Boultwood; Thomas Luft; Judith B Zaugg; Andrea Pellagatti; Peer Bork; Patrick Aloy; Anne-Claude Gavin; Anthony D Ho
Journal:  Nat Commun       Date:  2018-10-01       Impact factor: 14.919

10.  Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.

Authors:  Cristina Trento; Maria Ester Bernardo; Arnon Nagler; Selim Kuçi; Martin Bornhäuser; Ulrike Köhl; Dirk Strunk; Antonio Galleu; Fermin Sanchez-Guijo; Giuseppe Gaipa; Martino Introna; Adomas Bukauskas; Katarina Le Blanc; Jane Apperley; Helene Roelofs; Ann Van Campenhout; Yves Beguin; Jürgen Kuball; Lorenza Lazzari; Maria Antonietta Avanzini; Willem Fibbe; Christian Chabannon; Chiara Bonini; Francesco Dazzi
Journal:  Biol Blood Marrow Transplant       Date:  2018-07-20       Impact factor: 5.742

View more
  2 in total

Review 1.  Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products.

Authors:  Makoto Murata; Takanori Teshima
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 7.561

Review 2.  Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review.

Authors:  Ying Li; Jie Hao; Zheng Hu; Yong-Guang Yang; Qi Zhou; Liguang Sun; Jun Wu
Journal:  Stem Cell Res Ther       Date:  2022-03-04       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.